Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Get Free Report) shot up 5.9% during mid-day trading on Wednesday . The stock traded as high as $124.37 and last traded at $124.01. 550,813 shares traded hands during trading, a decline of 43% from the average session volume of 972,684 shares. The stock had previously closed at […]
First Horizon Advisors Inc. increased its holdings in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) by 308.3% during the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 245 shares of the biotechnology company’s stock after purchasing an additional 185 shares during the period. First Horizon Advisors Inc.’s holdings in Sarepta Therapeutics were […]
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) had its price target dropped by equities researchers at Needham & Company LLC from $185.00 to $82.00 in a report released on Tuesday, Benzinga reports. The firm presently has a “buy” rating on the biotechnology company’s stock. Needham & Company LLC’s target price indicates a potential upside of […]
Mackenzie Financial Corp cut its stake in Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) by 19.5% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 32,847 shares of the biotechnology company’s stock after selling 7,935 shares during the period. Mackenzie Financial Corp’s holdings […]
Royal Bank of Canada Lowers Sarepta Therapeutics (NASDAQ:SRPT) Price Target to $148 00 kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.